Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127611491 | 12761149 | 1 | I | 20151209 | 20160920 | 20160920 | PER | US-STRIDES ARCOLAB LIMITED-2015SP002252 | STRIDES | DICKERSON RN, BERRY SC, ZIEBARTH JD, SWANSON JM, MAISH GO, MINARD G, BROWN RO. DOSERESPONSE EFFECT OF ERGOCALCIFEROL THERAPY ON SERUM 25HYDROXYVITAMIN D CONCENTRATION DURING CRITICAL ILLNESS.. NUTRITION. 2015;10:1219-1223 | 0.00 | Y | 0.00000 | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127611491 | 12761149 | 1 | PS | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 50000 IU, 2 TIMES A WEEK | 90455 | 50000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127611491 | 12761149 | 1 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127611491 | 12761149 | Hypercalcaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |